Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an ubiquitous glycolytic enzyme present in reasonably high levels in almost all tissues.
This report contains market size and forecasts of GAPDH Antibody in global, including the following market information:
Global GAPDH Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GAPDH Antibody Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five GAPDH Antibody companies in 2021 (%)
The global GAPDH Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GAPDH Antibody From Rabbit Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GAPDH Antibody include LifeSpan BioSciences, United States Biological, OriGene, Creative Biolabs, Abbexa, Abcam, Bioss, Creative Diagnostics and GenWay Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GAPDH Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GAPDH Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global GAPDH Antibody Market Segment Percentages, by Type, 2021 (%)
GAPDH Antibody From Rabbit
GAPDH Antibody From Mouse
GAPDH Antibody From Goat
GAPDH Antibody From Sheep
GAPDH Antibody From Chicken
Global GAPDH Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global GAPDH Antibody Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global GAPDH Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global GAPDH Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GAPDH Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GAPDH Antibody revenues share in global market, 2021 (%)
Key companies GAPDH Antibody sales in global market, 2017-2022 (Estimated), (Kg)
Key companies GAPDH Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LifeSpan BioSciences
United States Biological
OriGene
Creative Biolabs
Abbexa
Abcam
Bioss
Creative Diagnostics
GenWay Biotech
Biorbyt
Taiclone
Biotrend
Bio-Techne
Merck
Aviva Systems Biology
Thermo Fisher Scientific
Sino Biologica